Document is current
Any future updates will be listed below
-
Authors
Ceric, Ameldina
Dankiewicz, Josef
Cronberg, Tobias
Düring, Joachim
Moseby-Knappe, Marion
Annborn, Martin
May, Teresa L.
Thomas, Matthew
Grejs, Anders Morten
Rylander, Christian
Belohlavek, Jan
Wendel-Garcia, Pedro
Haenggi, Matthias
Schrag, Claudia
Hilty, Matthias P.
Keeble, Thomas R.
Wise, Matt P.
Young, Paul
Taccone, Fabio Silvio
Robba, Chiara
Cariou, Alain
Eastwood, Glenn
Saxena, Manoj
Ullén, Susann
Lilja, Gisela
Jakobsen, Janus C.
Lybeck, Anna
Nielsen, Niklas
-
Funding
Funding for this research was provided by:
Lund University
- License Information
-
More Information
Article History
Received: 4 March 2025
Accepted: 15 May 2025
First Online: 17 June 2025
Declarations
:
: The TTM2-trial was approved by Regional Ethical Review Board in Lund, Sweden (Nr 2015/228 and 2017/36) and in all participating countries and was carried out in accordance with the World Medical Association’s Declaration of Helsinki. Written informed consent was waived, deferred, or obtained from a legal surrogate, depending on the circumstances, and was obtained from each patient who regained mental capacity. For this sub analysis, no further ethical approval was required.
: Not applicable.
: The authors declare no competing interests.
